Ingevity Corp buy BMO Capital Markets
Start price
07.08.25
/
50%
€40.88
Target price
07.08.26
€53.17
Performance (%)
63.89%
End price
08.08.26
€67.00
Summary
This prediction ended on 08.08.26 with a price of €67.00. With a performance of 63.89% the BUY prediction by BMO_Capital_Markets was a big success. BMO_Capital_Markets has a follow-up prediction for Ingevity Corp where he still thinks Ingevity Corp is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ingevity Corp | -3.788% | -3.788% | 33.910% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity Corporation (NYSE: NGVT) had its price target raised by analysts at BMO Capital Markets from $56.00 to $62.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat
In the thread Trading Ingevity Corp
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten